Tidal Trust II YieldMax BRK.B Option Income Strategy ETF (ARCA: BRKC)

Ultime notizie per Tidal Trust II YieldMax BRK.B Option Income Strategy ETF (ARCA:BRKC)

The Fund is an actively managed exchange-traded fund (ETF) that seeks current income while providing indirect exposure to the share price (i.e., the price returns) of the common stock of Berkshire Hathaway Inc. (BRK.B or the Underlying Security), subject to a limit on potential investment gains. The Fund will seek to employ its investment strategy as it relates to BRK.B regardless of whether there are periods of adverse market, economic, or other conditions and will not seek to take temporary defensive positions during such periods. As further described below, the Fund uses either a synthetic covered or a synthetic covered call spread strategy call strategy to provide income and indirect exposure to the share price returns of BRK.B, subject to a limit on potential investment gains as a result of the nature of the options strategy it employs. That is, the Fund not only seeks to generate income from its options investments but also aims to derive gains when the value of BRK.B increases.

YieldMax BRK.B Option Income Strategy ETF

Tidal Trust II YieldMax BRK.B Option Income Strategy ETF

BARKSDALE RES CORP by Barksdale Resources Corp.

Barksdale Resources Corp

News

General

Chemed Says Vitas Projects $18M-$25M Medicare Cap Revenue Limitation For 2025

Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) has outperformed the market over the past 15 years by 10.67% on an annualized basis producing an average annual return of 23.33%. Currently, Taiwan Semiconductor has a market capitalization of $1.19 trillion. 
Buying $1000 In TSM: If an investor had bought $1000 of TSM stock 15 years ago, it would be worth $23,111.22 today based on a price of $228.57 for TSM at the time of writing.
<h3>Taiwan Semiconductor's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751057111_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much $1000 Invested In Taiwan Semiconductor 15 Years Ago Would Be Worth Today

MSGS

Madison Square Garden Sports Says Media Rights Deal Between Units Of Msg Networks Amended Effective January 1, 2025; New York Knicks Annual Rights Fee Reduced By 28%; New York Rangers Annual Rights Fee Reduced By 18%

<a href="https://www.youtube.com/watch?v=nWcpp2YU6xk">https://www.youtube.com/watch?v=nWcpp2YU6xk</a>

Macro Notification

Politics

Economics

President Trump Says Canada Difficult To Deal With; On Canada Says We Have All Cards; We Have Such Power Over Canada

<a href="https://www.bloomberg.com/news/articles/2025-06-27/trump-officials-met-with-walmart-on-direct-to-patient-drug-sales">https://www.bloomberg.com/news/articles/2025-06-27/trump-officials-met-with-walmart-on-direct-to-patient-drug-sales</a>

'Trump Officials Met with Walmart on Direct-to-Patient Drug Sales'- Bloomberg

Quantum BioPharma Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNTM#NASDAQ">QNTM</a>) (CSE:<a class="ticker" href="https://www.benzinga.com/stock/QNTM#CSE">QNTM</a>) (FRA: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce that it is completing a non-brokered private placement of class A multiple voting shares ("MVS") at a price of $50 per MVS, for aggregate gross proceeds of up to $600 (the "Offering"). The Company expects that the entirety of the Offering will be subscribed for by the existing holders of MVS.

Offerings

CSE:QNTM

QNTM

Quantum Biopharma Announces Private Placement

WIIM

VERO

Venus Concept shares are trading higher after Madryn Asset Management increased its stake in the company to 85.5%.

Insider Trades

DELL

Dell Technologies Form4 Filing Shows CEO Michael S Dell Sold 10M Shares At An Average Price Of $122.27/Share

Interactive Brokers Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>) has outperformed the market over the past 5 years by 24.08% on an annualized basis producing an average annual return of 38.88%. Currently, Interactive Brokers Group has a market capitalization of $23.52 billion. 
Buying $100 In IBKR: If an investor had bought $100 of IBKR stock 5 years ago, it would be worth $522.24 today based on a price of $53.96 for IBKR at the time of writing.
<h3>Interactive Brokers Group's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751056214_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

IBKR

$100 Invested In Interactive Brokers Group 5 Years Ago Would Be Worth This Much Today

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/ELLXF">Elixinol Wellness</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ELLXF#OTC">ELLXF</a>) shares closed up 145.45% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/LVRLF">CordovaCann</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LVRLF#OTC">LVRLF</a>) shares closed up 23.75% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 19.35% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/TGIFF">1933 Industries</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TGIFF#OTC">TGIFF</a>) shares closed up 15.79% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CXXIF">C21 Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CXXIF#OTC">CXXIF</a>) shares closed up 10.27% at $0.16</li>
<li><a href="https://www.benzinga.com/quote/CURR">Currenc Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURR#NASDAQ">CURR</a>) shares closed up 5.66% at $0.67</li>
<li><a href="https://www.benzinga.com/quote/YCBD">cbdMD</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) shares closed up 3.78% at $0.91</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/GBHPF">Global Hemp Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBHPF#OTC">GBHPF</a>) shares closed down 63.90% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed down 38.29% at $3.08</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed down 9.80% at $0.00</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed down 8.23% at $7.40</li>
<li><a href="https://www.benzinga.com/quote/SOLCF">SOL Global Investments</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SOLCF#OTC">SOLCF</a>) shares closed down 7.55% at $0.05</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 7.00% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed down 6.00% at $0.87</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 4.73% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed down 4.10% at $0.27</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Properties</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed down 4.00% at $0.51</li>
<li><a href="https://www.benzinga.com/quote/VFF">Village Farms Intl</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) shares closed down 3.57% at $1.07</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed down 3.40% at $0.30</li>
<li><a href="https://www.benzinga.com/quote/CPHRF">Cipher Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CPHRF#OTC">CPHRF</a>) shares closed down 3.25% at $9.24</li>
<li><a href="https://www.benzinga.com/quote/MXC">Mexco Energy</a> (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MXC#AMEX">MXC</a>) shares closed down 3.18% at $9.12</li>
<li><a href="https://www.benzinga.com/quote/RIV">Rivernorth Opps Fund</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIV#NYSE">RIV</a>) shares closed down 3.13% at $12.25</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed down 3.03% at $3.52</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

Movers

CPHRF

CRBP

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CXXIF

ELLXF

GBHPF

GNLN

GRWG

ITHUF

KAYS

LVRLF

NWVCF

RMHB

RSSFF

SOLCF

TCNNF

TGIFF

UGRO

YCBD

ZDPY

Cannabis Stock Movers For June 27, 2025

Venus Concept 13D Amended Filing Shows Madryn Asset Management Acquires 85.5% Stake In Co As Of June 25, 2025

<a href="https://www.fda.gov/news-events/press-announcements/fda-eliminates-risk-evaluation-and-mitigation-strategies-rems-autologous-chimeric-antigen-receptor" title="https://www.fda.gov/news-events/press-announcements/fda-eliminates-risk-evaluation-and-mitigation-strategies-rems-autologous-chimeric-antigen-receptor">https://www.fda.gov/news-events/press-announcements/fda-eliminates-risk-evaluation-and-mitigation-strategies-rems-autologous-chimeric-antigen-receptor</a>

Biotech

'FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor CAR T cell Immunotherapies; Agency determines the safety and effectiveness of these immunotherapies can be assured without a REMS' - FDA

<a href="https://www.youtube.com/watch?v=nWcpp2YU6xk">https://www.youtube.com/watch?v=nWcpp2YU6xk</a>
&nbsp;

Macro Economic Events

Global

Market Vectors Rare Earth/Strategic Metals Etf

REMX

President Trump Says Will Do Official Meeting With African Union In July; Trump's Africa Envoy Says Negotiating Mineral Deal With Congo And Looking At Deals With Rwanda And Supporting Lobito Corridor

PLRX

Pliant Therapeutics shares are trading higher. The company announced the voluntary discontinuation of BEACON-IPF.

GCMG

GCM Grosvenor Files For Mixed Shelf Of Up To $350M

<a href="https://www.bloomberg.com/news/articles/2025-06-27/ford-forced-to-idle-multiple-us-plants-on-china-magnet-shortage?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-27/ford-forced-to-idle-multiple-us-plants-on-china-magnet-shortage?embedded-checkout=true</a>

'Ford Forced to Idle Multiple US Plants on China Magnet Shortage'- Bloomberg

With news breaking earlier this morning that the U.S. and China have <a href="https://www.benzinga.com/news/politics/25/06/46133537/howard-lutnick-confirms-us-china-trade-agreement-reaffirms-white-houses-progress-to-close-deals-with-10-other-trading-partners">finalized a trade understanding</a>, the major equity indices bounced higher on Friday. However, Trump Media &amp; Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) suffered a conspicuous decline. While controversial in some circles because of its obvious ties to President Donald Trump, the media company's Truth Social platform will likely be relevant for at least the next three years. As such, DJT stock could be a compelling idea.
Undoubtedly, exposure to Trump Media is risky. Since the start of the year, DJT stock hemorrhaged about 49% of market value. Over the past 52 weeks, the security is down more than 52% at time of writing. However, it's also undeniable that DJT commands <a href="https://www.benzinga.com/m-a/24/03/37943780/exclusive-trump-media-company-goes-public-financial-experts-say-djt-a-meme-stock-this-is-going-to-be">meme-like qualities</a>. With the tremendous popularity of the Trump brand, the company that bears the president's name might not stay deflated indefinitely.
Whether one agrees with his politics or not, Trump has scored multiple victories. As stated earlier, his administration reached an agreement with Chinese diplomats. Among the key components of the trade agreement is China's commitment to supply rare earths, which represent critical commodities that undergird a wide array of products. Further, the negotiated terms indicate that there's a method to the madness, thereby instilling confidence in the president's leadership.
Another big win stemmed from U.S. forces striking key Iranian nuclear sites, which quickly led to a <a href="https://www.benzinga.com/markets/equities/25/06/46090358/us-stocks-likely-to-edge-higher-as-iran-israel-ceasefire-holds-micron-technology-general-mills-in-focus-ahead-of-earnings">ceasefire between Iran and Israel</a>. While the cessation of hostilities remains a fragile agreement, that the two sides have been willing to negotiate is nonetheless a massive political success for Trump. As the Cato Institute pointed out, Americans don't want to be <a href="https://www.cato.org/blog/americans-dont-want-another-war-middle-east">dragged</a> into another war in the Middle East. The use of force could have ended badly but didn't.
Even on the domestic front, Trump is winning. Just recently, The New York Times reported that the University of Virginia President James E. Ryan has stepped down due to <a href="https://www.nytimes.com/2025/06/27/us/politics/uva-president-resigns-jim-ryan-trump.html">pressure</a> from the Trump administration. Through the resignation, the academic institution will be able to help resolve a Justice Department inquiry regarding its diversity, equity and inclusion initiatives.
With Trump being emboldened by his successes, he could potentially become even more aggressive with his policies, thereby providing fuel for Truth Social.
<h2 class="wp-block-heading">Making A Technical And Statistical Case For DJT Stock</h2>
While the fundamental narrative may be attractive for DJT stock, at the end of the day, investors must be willing to buy the security. From the perspective of technical analysis, it's possible that DJT has reached — or is close to reaching — a support level. Again, given its meme-like qualities, the market may perceive the red ink as a discount.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="1000" height="596" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27152138/DJT-stock-technical-analysis.jpg" alt="" class="wp-image-965382" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27152138/DJT-stock-technical-analysis.jpg 1000w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27152138/DJT-stock-technical-analysis-300x179.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27152138/DJT-stock-technical-analysis-768x458.jpg 768w" sizes="(max-width: 1000px) 100vw, 1000px" /><figcaption class="wp-element-caption">Image by TradingView</figcaption></figure>
Still, the above represents a heuristic statement: DJT stock appears to have hit support because of the impact of an imaginary horizontal line. Technical analysts will often argue that support represents clusters of buy orders but the logic behind this is generally unsubstantiated.
Rather than assume the existence of buy orders — which is a presuppositional fallacy — I prefer empirically analyzing market demand. But in order to conduct such an analysis, the underlying dataset (the share price history of DJT stock) must speak a uniform language. As such, I convert the share price history into market breadth, which is the sequence of accumulative and distributive sessions.
At the moment, the price action of DJT stock can be converted as a "2-8-D" sequence: two up weeks, eight down weeks, with a negative trajectory across the 10-week period. Admittedly, this conversion process compresses DJT's magnitude dynamism into a simple binary code. However, binary codes are, by definition, discrete events, meaning that their boundaries are defined.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27152118/DJT-stock-10wk-forecast-1024x576.jpg" alt="" class="wp-image-965381" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27152118/DJT-stock-10wk-forecast-1024x576.jpg 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27152118/DJT-stock-10wk-forecast-300x169.jpg 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27152118/DJT-stock-10wk-forecast-768x432.jpg 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/27152118/DJT-stock-10wk-forecast.jpg 1280w" sizes="(max-width: 1024px) 100vw, 1024px" /><figcaption class="wp-element-caption">Image by author</figcaption></figure>
Scientifically, discrete events can be segregated into distinct categories, which can then serve as the basis for past analogs when conducting probabilistic analysis. With this framework, when the 2-8-D sequence flashes, the following week's price action has a 60% chance of upside, with a median return of 1.7%. Should the bulls maintain control of the market, DJT stock could see an 8.06% move in the second week.
<h2 class="wp-block-heading">A Tempting Offer On The Table</h2>
With the poor performance of DJT stock on Friday, market makers are in a giving mood. Subsequently, the 17.50/18.00 bull call spread expiring July 25 may represent a tempting idea. This transaction involves buying the $17.50 call and simultaneously selling the $18 call, for a net debit paid of $23 (the most that can be lost in the trade). Should DJT rise through the short strike price ($18) at expiration, the maximum reward is $27, a payout of over 117%.
This trade is enticing because you're given about four weeks for DJT stock to rise 4.4%. Based on past responses to the 2-8-D sequence, this is a realistic target. Further, as a baseline, the chance that DJT will rise over any given week is only 45.41%. However, past analogs demonstrate that investors historically buy the dips, making the current profile attractive.
Without converting continuous price signals into a binary code, I wouldn't be able to determine the probability of upside other than resorting to a trust-me-bro assertion. Combined with the fundamental speculation and the technical heuristics, the math seems to favor DJT stock. It's still a wildly risky wager but this way, you can gamble your "fun money" strategically and intelligently.
The opinions and views expressed in this content are those of the individual author and do not necessarily reflect the views of Benzinga. Benzinga is not responsible for the accuracy or reliability of any information provided herein. This content is for informational purposes only and should not be misconstrued as investment advice or a recommendation to buy or sell any security. Readers are asked not to rely on the opinions or information herein, and encouraged to do their own due diligence before making investing decisions.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/options/25/06/46127885/intc-stock-intel-china-restrictions-geopolitics">Options Corner: Intel Hides In Plain Sight Amid The Shifting Geopolitical Spotlight</a></li>
</ul>
Photo: Shutterstock

Equities

Long Ideas

Options

Options Corner: Trump Media Might Rally As Political Wins Stack Up

Federal Reserve

Live On CNBC, U.S. Secretary of the Treasury Scott Bessent Says Powell Doesn't Have To Leave Fed, He Can Stay On The Board But Not As Chair

Pennsylvania American Water to Invest Over $5 Million in First Five Years
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.amwater.com%2Fpaaw%2F&amp;esheet=54283289&amp;newsitemid=20250627925095&amp;lan=en-US&amp;anchor=Pennsylvania+American+Water&amp;index=1&amp;md5=f0f36c36dc87ec60af03eca6f5a393e1">Pennsylvania American Water</a> announced today that it signed an agreement with the City of Pittston to acquire its wastewater collection system for $26.4 million. The system serves approximately 4,400 customers throughout the city. Pennsylvania American Water is already the drinking water service provider for the City of Pittston and has more than 135,000 customer connections in the region.
As part of the agreement, Pennsylvania American Water has agreed to make necessary collection system upgrades, which are expected to total more than $5.1 million over five years. Specifically, the company plans to make significant investments in main replacements; technology updates; security and safety systems; and geographic information system improvements.
Pennsylvania American Water will seek all necessary approvals from its regulators and expects to close the transaction by late 2026.

Pennsylvania American Water Agrees With City Of Pittston To Acquire Its Wastewater Collection System For $26.4M

Intercontinental Exchange (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ICE#NYSE">ICE</a>) has outperformed the market over the past 10 years by 3.4% on an annualized basis producing an average annual return of 14.88%. Currently, Intercontinental Exchange has a market capitalization of $104.43 billion. 
Buying $1000 In ICE: If an investor had bought $1000 of ICE stock 10 years ago, it would be worth $4,025.65 today based on a price of $181.75 for ICE at the time of writing.
<h3>Intercontinental Exchange's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1751055312_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have This Much Today

Press Releases

YieldMax® Introduces Option Income Strategy ETF on Berkshire Hathaway Inc. (BRK.B)

BRKC

Comments

Tidal Trust II YieldMax BRK.B Option Income Strategy ETF

Notizie

Ultime notizie per Tidal Trust II YieldMax BRK.B Option Income Strategy ETF (ARCA:BRKC)

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO